Cargando…

Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score

BACKGROUND: Coronary artery disease (CAD) risk traditionally has been assessed using clinical risk factors. We evaluated whether molecular genetic markers for CAD risk could add information to traditional variables. METHODS: We developed a false discovery rate 267-marker genetic risk score (FDR(267)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Robin, Cheng, Jiahui, Muzlera, Carlos, Robinson, John F., Ban, Matthew R., Hegele, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063618/
https://www.ncbi.nlm.nih.gov/pubmed/32159086
http://dx.doi.org/10.1016/j.cjco.2019.01.003
_version_ 1783504724938457088
author Liu, Robin
Cheng, Jiahui
Muzlera, Carlos
Robinson, John F.
Ban, Matthew R.
Hegele, Robert A.
author_facet Liu, Robin
Cheng, Jiahui
Muzlera, Carlos
Robinson, John F.
Ban, Matthew R.
Hegele, Robert A.
author_sort Liu, Robin
collection PubMed
description BACKGROUND: Coronary artery disease (CAD) risk traditionally has been assessed using clinical risk factors. We evaluated whether molecular genetic markers for CAD risk could add information to traditional variables. METHODS: We developed a false discovery rate 267-marker genetic risk score (FDR(267)) from markers that were significantly associated with CAD in the UK Biobank cohort meta-analysis. FDR(267) was tested in the Atherosclerosis Risk in Communities cohort using logistic regression and Cox proportional hazards analyses in the European and African American groups. RESULTS: Our genetic risk score (FDR(267)) was associated with a 1.45 (95% confidence interval, 1.39-1.51) increase in odds ratio and a 1.32 (95% confidence interval, 1.26-1.38) increase in hazard ratio per standard deviation of the score. The score modestly improved the area under the curve (AUC) statistic when added to a clinical model (ΔAUC = 0.0112, P = 0.0002). FDR(267) predicted incident CAD (C-index = 0.60), although it did not improve on clinical risk factors (ΔAUC = 0.0159, P = 0.0965). Individuals in the top quintile of FDR(267) genetic risk were at approximately 2-fold increased risk compared with the bottom quintile, which is comparable to risk associated with self-reported family history. The performance of FDR(267) was less robust in the African American sample. CONCLUSIONS: FDR(267) is significantly associated with CAD in the European sample, with an effect size comparable to self-reported family history. FDR(267) discriminated between individuals with and without CAD, but did not improve CAD risk prediction over clinical variables. FDR(267) was less predictive of CAD risk in African Americans.
format Online
Article
Text
id pubmed-7063618
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-70636182020-03-10 Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score Liu, Robin Cheng, Jiahui Muzlera, Carlos Robinson, John F. Ban, Matthew R. Hegele, Robert A. CJC Open Original Article BACKGROUND: Coronary artery disease (CAD) risk traditionally has been assessed using clinical risk factors. We evaluated whether molecular genetic markers for CAD risk could add information to traditional variables. METHODS: We developed a false discovery rate 267-marker genetic risk score (FDR(267)) from markers that were significantly associated with CAD in the UK Biobank cohort meta-analysis. FDR(267) was tested in the Atherosclerosis Risk in Communities cohort using logistic regression and Cox proportional hazards analyses in the European and African American groups. RESULTS: Our genetic risk score (FDR(267)) was associated with a 1.45 (95% confidence interval, 1.39-1.51) increase in odds ratio and a 1.32 (95% confidence interval, 1.26-1.38) increase in hazard ratio per standard deviation of the score. The score modestly improved the area under the curve (AUC) statistic when added to a clinical model (ΔAUC = 0.0112, P = 0.0002). FDR(267) predicted incident CAD (C-index = 0.60), although it did not improve on clinical risk factors (ΔAUC = 0.0159, P = 0.0965). Individuals in the top quintile of FDR(267) genetic risk were at approximately 2-fold increased risk compared with the bottom quintile, which is comparable to risk associated with self-reported family history. The performance of FDR(267) was less robust in the African American sample. CONCLUSIONS: FDR(267) is significantly associated with CAD in the European sample, with an effect size comparable to self-reported family history. FDR(267) discriminated between individuals with and without CAD, but did not improve CAD risk prediction over clinical variables. FDR(267) was less predictive of CAD risk in African Americans. Elsevier 2019-03-29 /pmc/articles/PMC7063618/ /pubmed/32159086 http://dx.doi.org/10.1016/j.cjco.2019.01.003 Text en © 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Liu, Robin
Cheng, Jiahui
Muzlera, Carlos
Robinson, John F.
Ban, Matthew R.
Hegele, Robert A.
Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title_full Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title_fullStr Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title_full_unstemmed Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title_short Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score
title_sort clinical utility and practical considerations of a coronary artery disease genetic risk score
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063618/
https://www.ncbi.nlm.nih.gov/pubmed/32159086
http://dx.doi.org/10.1016/j.cjco.2019.01.003
work_keys_str_mv AT liurobin clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore
AT chengjiahui clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore
AT muzleracarlos clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore
AT robinsonjohnf clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore
AT banmatthewr clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore
AT hegeleroberta clinicalutilityandpracticalconsiderationsofacoronaryarterydiseasegeneticriskscore